NEW YORK (GenomeWeb News) – Bruker has filed with the US Securities and Exchange Commission for a secondary offering of 12 million shares of common stock by two members of the Laukien family not involved in the firm's business.

Bruker will not receive any of the proceeds from the sale of the stock through this offering, it noted.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.